Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-03-29
1984-07-03
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544 22, 544 25, A61K 31545, C07D50146
Patent
active
044579292
ABSTRACT:
Compounds of the formula ##STR1## wherein R.sup.1 is hydrogen or a conventional amino-protecting group, R.sup.2 and R.sup.3 each are independently methyl or ethyl, and R.sup.4 is methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, allyl, 2-butenyl, 3-butenyl, 2-hydoxyethyl, 3-hydroxypropyl, 2-(dimethylamino)ethyl, pyridylmethyl, pyridylethyl, benzyl or phenethyl, and nontoxic pharmaceutically acceptable acid addition salts and solvates thereof, as well as processes for their preparation, are disclosed. The compounds in which R.sup.1 is hydrogen are potent antibacterial agents.
REFERENCES:
patent: 4278671 (1981-07-01), Ochiai et al.
patent: 4278793 (1981-07-01), Durckheimer et al.
Kamachi Hajime
Naito Takayuki
Okumura Jun
Bristol-Myers Company
Coughlan, Jr. Paul M.
Lloyd Richard R.
LandOfFree
3-Quaternary ammonium methyl)-substituted cephalosporin derivati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Quaternary ammonium methyl)-substituted cephalosporin derivati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Quaternary ammonium methyl)-substituted cephalosporin derivati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1630173